Comparing nitisinone 2 mg and 10 mg in the treatment of alkaptonuria—An approach using statistical modelling
Abstract Background Outcomes from studies employing nitisinone 10 mg and 2 mg in alkaptonuria were compared. Patients and methods Sixty‐nine patients in each of the nitisinone (10 mg daily) and controls of suitability of nitisinone in alkaptonuria 2 (SONIA 2), as well as 37 and 23 in nitisinone (2 m...
Main Authors: | Lakshminarayan R. Ranganath, Anna M. Milan, Andrew T. Hughes, Milad Khedr, Brendan P. Norman, Mohammed Alsbou, Richard Imrich, Matthew Gornall, Nicolas Sireau, James A. Gallagher, Richard Jackson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | JIMD Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/jmd2.12261 |
Similar Items
-
Revisiting Quantification of Phenylalanine/Tyrosine Flux in the Ochronotic Pathway during Long-Term Nitisinone Treatment of Alkaptonuria
by: Lakshminarayan R. Ranganath, et al.
Published: (2022-09-01) -
Association of alkaptonuria and low dose nitisinone therapy with cataract formation in a large cohort of patients
by: Mohammad S. Z. Ahmad, et al.
Published: (2022-07-01) -
Vitiligo, alkaptonuria, and nitisinone—A report of three families and review of the literature
by: Lakshminarayan Ranganath, et al.
Published: (2021-09-01) -
Reversal of ochronotic pigmentation in alkaptonuria following nitisinone therapy: Analysis of data from the United Kingdom National Alkaptonuria Centre
by: Lakshminarayan R. Ranganath, et al.
Published: (2020-09-01) -
Evaluation of the serum metabolome of patients with alkaptonuria before and after two years of treatment with nitisinone using LC‐QTOF‐MS
by: Andrew S. Davison, et al.
Published: (2019-07-01)